ESPN’s Jerry Crasnick interviewed Jeff Bagwell. Bagwell flat denies ever using PEDs. He said he got big because of an almost obsessive weight-lifting regimen he began in the mind-90s. He ads that he believes his weight-lifting was a mistake and that it contributed to his shoulder injuries that ended his career.
At the same time he is not at all judgmental about those who did take PEDs. He flat-out admires Barry Bonds, Mark McGwire and Andy Pettitte, and does not judge them at all for the drugs they took.
As for the Hall of Fame:
Would I be honored to death to be in the Hall of Fame? Of course I would. But it doesn’t consume me at all. I loved every single part of what I did as a baseball player. But I’ve got my kids, I’ve got my family, and getting in the Hall of Fame isn’t going to affect my life one way or the other. And it won’t make me feel any better about my career … So much has gone on in the last eight or nine years, it’s kind of taken some of the valor off it for me. If I ever do get to the Hall of Fame and there are 40 guys sitting behind me thinking, ‘He took steroids,’ then it’s not even worth it to me. I don’t know if that sounds stupid. But it’s how I feel in a nutshell.”
We all know how this game works. Someone accuses — or refuses to actually accuse but does just as much in their own cowardly fashion — and the player denies. Then someone notes how even those who have proven to use have denied it, some even getting charged with perjury for doing so. It ultimately gets us nowhere.
I know this much, however: I have no idea if Jeff Bagwell took anything he wasn’t supposed to. But nor do those who are withholding their Hall of Fame votes from him. I also know that those who continue to withhold their Hall of Fame votes for him are necessarily calling him liar now, in addition to calling him a drug user. In their own sad way, anyway.
Yahoo Sports’ Jeff Passan reports that third baseman Jose Ramirez is finalizing a four-year extension with the Indians. The deal is said to be worth north of $30 million, and may crest $50 million if all options are exercised. While the extension won’t take effect until the 2018 season, it guarantees Ramirez a $26 million sum with two options worth $11 and $13 million and will give the Indians control of the infielder through the 2023 season.
Ramirez, 24, is entering his fifth season in the Indians’ organization. He posted career-high numbers during his first full season in the majors, slashing .312/.363/.461 with 11 home runs, 22 stolen bases and 4.8 fWAR in 2016. He’s projected to have a strong follow-up season at the plate and will likely see some time at second base as Jason Kipnis works his way back from a shoulder injury.
Although 2016 only showcased the beginning of Ramirez’s success with the club, FanRag Sports’ Jon Heyman says it’s a standard move for Cleveland to “sign their stars early,” and indicates that Ramirez was rumored to want the deal. Jeff Todd of MLB Trade Rumors adds that the extension will keep Ramirez under club control through three arbitration-eligible years and one year of potential free agency.
Diamondbacks’ right-hander Tyler Jones is headed back to the Yankees, the teams announced on Friday. The Diamondbacks had previously selected Jones in the Rule 5 draft last December, but elected to leave the 27-year-old off of their 40-man roster heading into the 2017 season. Rule 5 draft rules stipulate that when a player is not kept on the receiving team’s roster, the player must be offered back to his original team.
Jones signed a minor league contract with the Yankees prior to the 2016 season. He pitched to an impressive 2.17 ERA, 2.2 BB/9 and 13.2 SO/9 over 45 2/3 innings with Double-A Trenton, but was unable to make the leap to Triple-A or beyond during his stay with the organization.
Jones’ outlook with the Diamondbacks appeared slightly more promising. GM Mike Hazen described the righty as a power arm with a “good fastball and power curveball” after selecting him in the Rule 5 draft, and early reports indicated that Jones would be in the mix for a bullpen spot. A rough spring performance — underscored by his lack of experience at the Triple-A and major league levels — undid most of that confidence, however, and the Diamondbacks weren’t willing to keep him on the active roster throughout the entire 2017 season in order to acquire his control rights.
Jones is set to open the season with Triple-A Scranton/Wilkes-Barre, per a report from the Yankees.